Ïã¸ÛÁùºÏ²Ê

XClose

Joint Research Office

Home
Menu

Commercial research at Ïã¸ÛÁùºÏ²ÊH and Ïã¸ÛÁùºÏ²Ê

Working with industry is an important part of our research strategy at Ïã¸ÛÁùºÏ²ÊH and Ïã¸ÛÁùºÏ²Ê.

Joining forces in this way has enabled us to drive improvements in patient care through research.

Our work with industry involves hosting industry sponsored studies and strategic partnerships at Ïã¸ÛÁùºÏ²ÊH and Ïã¸ÛÁùºÏ²Ê, and collaborative research studies that we carry out with industry partners.

This work is supported by a range of supporting services and expertise including within the Ïã¸ÛÁùºÏ²ÊH/Ïã¸ÛÁùºÏ²Ê Joint Research Office, Ïã¸ÛÁùºÏ²ÊH Clinical Research Facility, and a dedicated Translational Research Office at Ïã¸ÛÁùºÏ²Ê.

Why do research at Ïã¸ÛÁùºÏ²ÊH?

Ïã¸ÛÁùºÏ²ÊH, situated in the heart of London’s knowledge quarter, is one the largest NHS trusts in the UK, and delivers first-class care and research.

As a world-leading NHS-university partnership at Ïã¸ÛÁùºÏ²ÊH and Ïã¸ÛÁùºÏ²Ê, we can offer industry partners:

  • world-class scientific expertise including key leaders in disease areas
  • support with identifying Principal Investigators for expressions of interest
  • an excellent and capable research delivery workforce
  • world-class infrastructure including a dedicated Clinical Research Facility for early phase studies
  • one standardised capacity and capability process with transparent timelines and compatible with HRA requirements
  • well supported services and expert support and technical services at Ïã¸ÛÁùºÏ²ÊH, capable of delivering complex research protocols. 
  • Diverse patient populations
  • unparalleled access to rare diseases via our specialist hospitals
  • research support points of contact throughout the research life cycle including the opportunity for regular site-sponsor meetings to discuss escalations and strategic matters
  • finally, we are dedicating efforts to ensuring that everyone has the chance to take part in research – no matter what their background.

Clinical specialties and infrastructure

It comprises 10 hospitals including and services in cancer, neurology and infectious diseases.

It hosts the only dedicated in the UK for early-phase neurology studies and are one of only two UK centres for research.

.

Set up of Commercial studies at Ïã¸ÛÁùºÏ²ÊH

Expressions of interest

We are fully supportive of sponsors and CROs sending new expressions of interest directly to Ïã¸ÛÁùºÏ²ÊH and Ïã¸ÛÁùºÏ²Ê researchers. 

A list of Consultants working at Ïã¸ÛÁùºÏ²ÊH can be found on the . Sponsors and CRO’s interested in contacting cancer specific researchers are also able to contact the Ïã¸ÛÁùºÏ²ÊH Cancer Clinical Trials Unit to share expressions of interest.

A list of current open studies including PIs and the studies’ specialities can be found through the public trials database at Ïã¸ÛÁùºÏ²ÊH .

Alternatively, expressions of Interest can be sent to: uclh.commercial-research@nhs.net.

Capacity and Capability

The main office for Capacity and Capability (C&C) (also referred to as AAC) assessments (site approvals) is the Ïã¸ÛÁùºÏ²ÊH/Ïã¸ÛÁùºÏ²Ê Joint Research Office (JRO). The Cancer Clinical Trials Unit (CCTU) at Ïã¸ÛÁùºÏ²ÊH and the Clinical Research Facility (CRF) will also coordinate C&C for studies happening within their respective areas.

Where CDA’s are required they should be sent to the JRO, CCTU or the CRF (as applicable).

The set-up process for Ïã¸ÛÁùºÏ²ÊH includes close collaboration and a single, standard procedure which includes finance, contracting, governance, and clinical support and technical departments. This includes imaging, pharmacy, nuclear medicine, pathology and information governance. This single and collaborative process can identify and respond to issues and adapt to study requirements.

Ïã¸ÛÁùºÏ²ÊH is an active contributor to national initiatives to improve the delivery of research in the NHS – for instance the National Contract Value Review (NCVR), Health Research Authority requirements for site set-up and model contracts.

Read more about the requirements for set-up at Ïã¸ÛÁùºÏ²ÊH, on the JRO Assess, Arrange and Confirm (AAC) pages

Innovations and Collaboration in research

At Ïã¸ÛÁùºÏ²ÊH and Ïã¸ÛÁùºÏ²Ê, we are innovating in the way we deliver research.

We are leaders in digital-enabled research – Ïã¸ÛÁùºÏ²ÊH having in place a hospitals-wide electronic health record and a which provides us with the robust environment and infrastructure necessary for the analysis of clinical data.

We are trialling designed to improve research efficiency, and developing research based on ‘nudge randomisation’ – an innovation in trial design where clinicians are automatically prompted by an alert in the electronic health record to consider whether a patient may be suitable for a clinical trial.

We have rolled out research using novel trial designs where multiple interventions can be trialled at the same time – rather than .

We are developing methodologies and partnerships for decentralised research – enabling our trials to take place outside of the hospital setting – for example through remote monitoring of research participants and trial follow up in the community and primary care.

Ïã¸ÛÁùºÏ²Ê has a dedicated Translational Research Office, supported by our NIHR Ïã¸ÛÁùºÏ²ÊH Biomedical Research Centre which has specialist staff to develop scientific partnerships and collaborations with industry partners.

Best practice in set up of commercial studies

Ïã¸ÛÁùºÏ²ÊH was central to the development of published in 2023 aimed at improving the process of commercial clinical trial set-up in the UK.

The guidance was developed by NHS and industry representatives through a process co-led by Ïã¸ÛÁùºÏ²ÊH/Ïã¸ÛÁùºÏ²Ê Managing Director for Research Dr Nick McNally, who is chair of UK Research & Development (UKRD), a representative body for R&D leaders in the NHS.

The guide aims to reduce the amount of time taken to set up research and in so doing to increase patients’ access to research.

A 2024 audit at Ïã¸ÛÁùºÏ²ÊH showed we are compliant with this best practice guidance in almost all areas. We are working with our industry partners to align completely with this national guidance.

Single point of contact

If you are interested in working with Ïã¸ÛÁùºÏ²ÊH and Ïã¸ÛÁùºÏ²Ê, in the first instance please contact: uclh.commercial-research@nhs.net.